Clinical Trial Update: Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating oxaliplatin with or without floxuridine and leucovorin in metastatic cancer of the peritoneum has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Carcinomatosis

Drugs mentioned

• Eloxatin (oxaliplatin)
• Floxuridine (floxuridine)
• Wellcovorin (leucovorin calcium)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Cancer | Phase 1 | Status: COMPLETED